ATE537184T1 - Neue cxc-chemokin-antagonisten - Google Patents

Neue cxc-chemokin-antagonisten

Info

Publication number
ATE537184T1
ATE537184T1 AT06807665T AT06807665T ATE537184T1 AT E537184 T1 ATE537184 T1 AT E537184T1 AT 06807665 T AT06807665 T AT 06807665T AT 06807665 T AT06807665 T AT 06807665T AT E537184 T1 ATE537184 T1 AT E537184T1
Authority
AT
Austria
Prior art keywords
new
cxc chemokine
chemokine antagonists
cxc
chemokine
Prior art date
Application number
AT06807665T
Other languages
English (en)
Inventor
Amanda Proudfoot
Christine Power
Original Assignee
Merck Serono Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Serono Sa filed Critical Merck Serono Sa
Application granted granted Critical
Publication of ATE537184T1 publication Critical patent/ATE537184T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43513—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae
    • C07K14/43527—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae from ticks
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Immunology (AREA)
  • Insects & Arthropods (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Pain & Pain Management (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Transplantation (AREA)
AT06807665T 2005-10-31 2006-10-30 Neue cxc-chemokin-antagonisten ATE537184T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP05110205 2005-10-31
US73354705P 2005-11-04 2005-11-04
PCT/EP2006/067939 WO2007051781A1 (en) 2005-10-31 2006-10-30 Novel cxc-chemokine antagonists

Publications (1)

Publication Number Publication Date
ATE537184T1 true ATE537184T1 (de) 2011-12-15

Family

ID=35953939

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06807665T ATE537184T1 (de) 2005-10-31 2006-10-30 Neue cxc-chemokin-antagonisten

Country Status (8)

Country Link
US (1) US7670802B2 (de)
EP (1) EP1943272B1 (de)
JP (1) JP2009513124A (de)
AT (1) ATE537184T1 (de)
AU (1) AU2006310573B2 (de)
CA (1) CA2617723A1 (de)
ES (1) ES2379192T3 (de)
WO (1) WO2007051781A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1984392B1 (de) * 2006-02-16 2012-08-08 Merck Serono SA Neue cc-chemokin-antagonisten
GB201603631D0 (en) * 2016-03-02 2016-04-13 Isis Innovation Therapy and diagnostics
CN112358547A (zh) * 2020-09-30 2021-02-12 浙江大学 抗人cxcl-2单克隆抗体3-d3及其编码基因和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000027873A2 (en) 1998-11-06 2000-05-18 Research Corporation Technologies, Inc. Interleukin-2 binding protein from arthropods
WO2001058941A1 (en) 2000-02-11 2001-08-16 Evolutec Limited Cytokine activity regulator molecules from tick salivary glands
AU2002339171A1 (en) * 2002-11-14 2004-06-03 Cambridge University Technical Services Limited Therapeutic modulation of chemokines using a helminth parasite chemokine-binding protein
ATE394117T1 (de) * 2002-12-23 2008-05-15 Serono Lab Verwendung von cc-chemokine ccl5/rantes mutanten zur behandlung von lebererkrankungen
EP1697404B1 (de) 2003-12-24 2009-07-22 Merck Serono SA Cc-chemokin-bindende zeckenproteine
US7838640B2 (en) * 2004-03-02 2010-11-23 Cellfree Sciences Co., Ltd. Method of producing cell extract for cell-free protein synthesis

Also Published As

Publication number Publication date
CA2617723A1 (en) 2007-05-10
US7670802B2 (en) 2010-03-02
EP1943272B1 (de) 2011-12-14
AU2006310573A1 (en) 2007-05-10
US20080227711A1 (en) 2008-09-18
AU2006310573B2 (en) 2012-01-19
ES2379192T3 (es) 2012-04-23
EP1943272A1 (de) 2008-07-16
JP2009513124A (ja) 2009-04-02
WO2007051781A1 (en) 2007-05-10

Similar Documents

Publication Publication Date Title
HN2005000477A (es) Compuestos de aminoheteroarilo sustituidos con piraol como inhibidores de proteina quinasa
ATE396199T1 (de) Antimikrobielles polypeptid
BG66084B1 (bg) Циклопентаноиндоли, състави,съдържащи такива съединения и използването им
DE60334973D1 (de) Aerosol-formulierungen von diisobutyryl apomorphine
CR8193A (es) Piperazina con o sustituida de grupos feniles y su uso como inhibidores de glyt 1
WO2006131564A3 (de) Neue cystein-verarmte hydrophobinfusionsproteine, deren herstellung und verwendung
ATE432323T1 (de) Bitumenzusammensetzung
EP1503795A4 (de) Verwendung von hitzschockproteinen zur verstärkung der wirksamkeit von antikörper-therapeutika
TW200603823A (en) Novel use of peptide compounds for treating essential tremor and other tremor syndromes
ATE370954T1 (de) Kristallform von asenapinmaleat
EA200602242A1 (ru) 3-аминоциклопентанкарбоксамиды в качестве модуляторов хемокиновых рецепторов
DE602006017980D1 (de) 3,4-substituierte pyrrolidin-derivate zur behandlung von hypertonie
DE602004023529D1 (de) Regelung der Güte (Q) von Filtern
DE60203299D1 (de) Fungizide zusammensetzung und verwendung dieser zusammensetzung zur bekämpfung von pflanzenkrankheiten
NO20080265L (no) 2-(1H-indolylsulfanyl)-arylaminderivater
ATE484749T1 (de) Von anti-trichinella-antikörpern erkannte polypeptide und ihre verwendung
DE602005012381D1 (de) Impfstoff der einen attenuierten pestivirus enthält
EA200801351A1 (ru) Фунгицидные смеси, которые содержат боскалид и пириметанил
AR054165A1 (es) Proteinas de union a il-6
DE602005020770D1 (de) Verwendungen des extrakts gymnema sylvestris
CL2008003182A1 (es) Compuestos derivados de 1,2,4-triazol-3-amino; composicion farmaceutica; y su uso en el tratamiento del dolor, reflujo gastroesofagico, ansiedad, sindrome del intestino irritable.
DE602006001396D1 (de) Aminhärtende epoxidharzzusammensetzungen mit einem lacton mit geringer schwindung
ATE537184T1 (de) Neue cxc-chemokin-antagonisten
TW200745039A (en) Isotopically substituted pantoprazole
DE112005001951B8 (de) Piezoelektrische Keramikzusammensetzung und ihre Verwendung